First Trust Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.56M | Buy |
|
|||||
|
2025
Q1 | $5.87M | Sell |
|
|||||
|
2024
Q4 | $46.6M | Sell |
|
|||||
|
2024
Q3 | $48.3M | Sell |
|
|||||
|
2024
Q2 | $38.3M | Buy |
|
|||||
|
2024
Q1 | $3.57M | Buy |
|
|||||
|
2023
Q4 | $1.68M | Buy |
|
|||||
|
2023
Q3 | $1.1M | Sell |
|
|||||
|
2023
Q2 | $2.21M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.11M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1M | Sell |
|
|||||
|
2022
Q1 | $1.22M | Sell |
|
|||||
|
2021
Q4 | $1.05M | Buy |
|
|||||
|
2021
Q3 | $722K | Sell |
|
|||||
|
2021
Q2 | $1.4M | Sell |
|
|||||
|
2021
Q1 | $1.17M | Buy |
|
|||||
|
2020
Q4 | $779K | Sell |
|
|||||
|
2020
Q3 | $723K | Buy |
|